Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).

Yonggang Li,Jian Zhang,Wenfang Xu,Huawei Zhu,Xun Li

DOI: https://doi.org/10.1016/j.bmc.2010.01.008

IF: 3.461

2010-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel quinoxalinone peptidomimetic derivatives (A1–A19) were synthesized and evaluated for their in vitro enzymatic inhibitory activities against aminopeptidase N (APN/CD13) and MMP-2.

What problem does this paper attempt to address?

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Xian-Chao Cheng,Qiang Wang,Hao Fang,Wei Tang,Wen-Fang Xu

DOI: https://doi.org/10.1016/j.ejmech.2007.12.020

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The hydroxamates 8a-c were equally or more potent MMP-2 inhibitors than the positive control LY52. The binding mode of the most potent compound 8a with MMP-2 was proposed. Structure-activity relationships were also briefly discussed.
Novel 3-Galloylamido-n′-substituted-2,6-piperidinedione-n-acetamide Peptidomimetics As Metalloproteinase Inhibitors

Qianbin Li,Hao Fang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmcl.2006.12.095

IF: 2.94

2007-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:Both of aminopeptidase N (APN) and matrix metalloproteinase (MMP) are essential metallopeptidases in the development of tumor invasion and angiogenesis. Novel potent peptidomimetic inhibitors, containing 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide, have been designed and synthesized according to the conformational constraint strategy. The preliminary biological test showed that most of the compounds displayed high inhibitory activity against MMP-2 and low activity against APN except compounds 6 (IC(50)=3.1microM) and 4l (IC(50)=5.2microM) which exhibit similar potency to Bestatin (IC(50)=2.4microM).
Design, Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Aminopeptidase N/CD13 Inhibitors.

Xiaopan Zhang,Jian Zhang,Lei Zhang,Jinghong Feng,Yingying Xu,Yumei Yuan,Hao Fang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmc.2011.08.041

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives were designed, synthesized and assayed for their activities against aminopeptidase N (APN/CD13) and MMP-2. The results showed that most compounds exhibited higher inhibitory activities against APN than that of MMP-2. Within this series, compound 12h (IC(50)=6.28 ± 0.11 μM) showed similar inhibitory activities compared with Bestatin (IC(50)=5.55 ± 0.01 μM), and it could be used as novel lead compound for the future APN inhibitors development as anticancer agents.
[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].

H. Jia,Yan-shen Guo,Yi-yu Ge,Hui Wen,Jing Yang,Xiu-ying Yang,G. Du,Guang-zhong Yang

2007-12-01

Abstract:A novel inhibitor series for matrix metalloproteinases (MMPs) were designed and synthesized. Using succinate and malonate as zinc binding groups and long hydrophobic substituents to bind with S1' pockets, the compounds showed micromolar inhibition and selectivity for MMP-2 over others. And we found a better activity compound. It is a chance to find a better precursor of MMP-2 inhibitors with activity and bioavailability by further optimization of compounds.

Chemistry
Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Jian Zhang,Xun Li,Huawei Zhu,Qiang Wang,Jinhong Feng,Jiajia Mou,Yonggang Li,Hao Fang,Wenfang Xu

2010-01-01

Abstract:A series of novel pyrrolidine derivatives was designed, synthesized, and assayed to determine the derivatives' activity against matrix metalloproteinase-2 (MMP-2) and aminopeptidase N (APN)/CD13. Preliminary biological tests showed that most compounds inhibit MMP-2 in a highly selective manner compared to APN. Compounds 9d, 9e, and 9g had better inhibitory activity than LY52 and could be used as lead compounds in the future.
Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.

Chen Chen,Xinying Yang,Hao Fang,Xuben Hou

DOI: https://doi.org/10.1016/j.ejmech.2019.111563

IF: 7.088

2019-01-01

European Journal of Medicinal Chemistry

Abstract:Matrix metalloproteinases (MMPs) play important roles in many diseases including cancer. With moderate metal-binding affinity, 8-hydroxyquinoline has gained much interest in current drug design and development. Specially, it has been reported that 8-hydroxyquinoline derivatives serve as MMP-2 inhibitors with micromolar IC50 values. In the current study, a series of 8-hydroxyquinoline derivatives were designed and synthesized as new MMP-2 and MMP-9 inhibitors. The most active compounds 5e and 5h not only displayed good inhibitory activities against MMP-2/9 with IC50 at submicromolar level, but also possessed potent anti-proliferative, anti-invasive and anti-angiogenesis activity in A549 cell line. Western blot also revealed that 5e and 5h down-regulate the expression of MMP-2 and MMP-9 in A549 cell line. Moreover, flow cytometry analysis indicated that compound 5e could promote apoptosis of A549 cells in vitro. Molecular docking analysis also revealed favorable binding modes of 5e in the active sites of MMP-2 and MMP-9.
Novel Aminopeptidase N Inhibitors Derived from Antineoplaston AS2–5 (part I)

Xun Li,Yazhou Wang,Jifeng Wu,Yonggang Li,Qiang Wang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmc.2009.03.017

IF: 3.461

2009-01-01

Bioorganic & Medicinal Chemistry

Abstract:As our ongoing work, a series of peptidomimetic L-iso-glutamine derivatives derived from antineoplaston AS2-5 scaffold were prepared and their APN/CD13 and MMP-2 inhibitory activities were evaluated hereby. The results displayed that these compounds exhibited selective inhibition against APN as compared with MMP-2, with IC(50) values in micromole range. Compounds A1 and A2 showed comparable APN inhibitory activities than the positive control bestatin.
The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Shao-hua Li,Gang Li,Hui-ming Huang,Fang Xiong,Cheng-mei Liu,Guo-gang Tu

DOI: https://doi.org/10.1007/s12272-001-2101-6

2008-01-01

Archives of Pharmacal Research

Abstract:Both the aminopeptidase N (APN) and matrix metalloproteinase (MMP) are essential metallopeptidases in the development of tumor invasion and angiogenesis. A series of novel peptide-like derivatives were designed and synthesized as antitumor agents. Their structures were confirmed by IR, MS, and (1)H-NMR. These compounds exhibited potent inhibitory activities against APN and low activity against MMP in vitro. The derivatives with methoxy group show better activities than those with other substituted group and could be used as lead compounds for exploring new APN inhibitors in the future.
Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

Jian Zhang,Xiaoyang Li,Yuqi Jiang,Jinhong Feng,Xiaoguang Li,Yingjie Zhang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmc.2013.12.025

IF: 3.461

2013-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel α-sulfonyl γ-(glycinyl-amino)proline peptidomimetic derivatives were designed, synthesized and assayed for their activities against matrix metalloproteinase-2 (MMP-2), aminopeptidase N (APN)/CD13 and HDACs. The results indicated that all the compounds exhibited highly selective inhibition against MMP-2 as compared with APN and HDACs. The antiproliferative activities of some compounds against SKOV3, HL60 and A549 cells were also investigated. Comparing with the control LY52, compound 12u, with excellent activity both in the enzymatic inhibition assay and cell-based assay, could be used as lead compound for the further development of MMP inhibitors.
Synthesis and Biological Evaluation of Novel Benzofuroxan-Based Pyrrolidine Hydroxamates As Matrix Metalloproteinase Inhibitors with Nitric Oxide Releasing Activity.

Hao Zhang,Xuejian Wang,Jing Mao,Yongxue Huang,Wenfang Xu,Yu Duan,Jian Zhang

DOI: https://doi.org/10.1016/j.bmc.2018.06.023

IF: 3.461

2018-01-01

Bioorganic & Medicinal Chemistry

Abstract:On the basis of the strategy of "multifunctional drugs", a series of novel matrix metalloproteinase inhibitors (MMPIs) containing benzofuroxan scaffold as a nitric oxide donor were designed, synthesized and evaluated. All synthesized compounds, especially 16a, exhibited potent MMP-2,9 inhibitory activities, anti-proliferative activities and could produce high levels of NO in Hela cells. They were also evaluated for both of their anti-invasion and anti-angiogenesis effects. Furthermore, compared with LY52, 16a demonstrated competitive antitumor activity in vivo. These hybrid NO-MMPIs might offer suitable scaffolds to develop valuable MMP inhibitors for the further discovery of novel anti-cancer drugs.
Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).

Chunhua Ma,Xiaoguang Li,Xuewu Liang,Kang Jin,Jiangying Cao,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmcl.2013.06.058

IF: 2.94

2013-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:Most zinc metalloproteases are over-expressed in tumor cells and play a critical role in the genesis, development, and metastasis of tumors. Novel zinc binding groups (ZBGs) represent a novel strategy to obtain optimal potency and selectivity for zinc metalloproteases inhibitors. Here we described the design, synthesis, and biological studies of novel β-dicarbonyl derivatives as aminopeptidase N (APN/CD13) inhibitors. The results demonstrated that some compounds exhibited moderate to good inhibitory activities against APN with compound 5c being the most potent, suggesting that 5c could serve as new lead for the future APN inhibitor development. The results further confirm our design rationale of β-dicarbonyl moiety as a new ZBG, which may provide a new direction for the design and discovery of zinc metalloproteases inhibitors as new anti-tumor agents.
Synthesis of New Sulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Xian-Chao Cheng,Qiang Wang,Hao Fang,Wei Tang,Wen-Fang Xu

DOI: https://doi.org/10.1016/j.bmc.2008.07.073

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of new sulfonyl pyrrolidine derivatives was designed, synthesized, and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The compounds 4c, 4j, 5a, and 5b were equally or more potent MMP-2 inhibitors than the positive control LY52. The FlexX docking was done to explain the reason for the different potency between MMP-2 and AP-N. Structure–activity relationships were also briefly discussed.
Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Xian-Chao Cheng,Qiang Wang,Hao Fang,Wen-Fang Xu

DOI: https://doi.org/10.2174/092986708783497373

IF: 4.74

2008-01-01

Current Medicinal Chemistry

Abstract:Matrix metalloproteinases (MMPs) play an important role in many physiological and pathological processes. MMP inhibitors have been considered as potential therapeutics for neoplasitc, rheumatic and cardiovascular diseases. Our group and others have been developing pyrrolidine scaffold-based MMP inhibitors for a number of years, and numerous compounds have been reported in the literature. These compounds can be classified as sulfonamide pyrrolidine derivatives, proline-containing peptidomimetics and acyl pyrrolidine derivatives. These synthetic MMP inhibitors show low nanomolar activity for some MMP subclasses, thus confirming pyrrolidine ring an excellent scaffold from which to design MMP inhibitors. This review will focus primarily on the structure, activity and selectivity profiles of pyrrolidine scaffold-based MMP inhibitors.
Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.

GuoGang Tu,ShaoHua Li,HuiMing Huang,Gang Li,Fang Xiong,Xi Mai,HuaWei Zhu,BinHai Kuang,Wen Fang Xu

DOI: https://doi.org/10.1016/j.bmc.2008.05.081

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:The synthesis and biological activity of a new series of 1,3,4-thiadiazole scaffold is described.
Design, Synthesis and Preliminary Activity Evaluation of Novel Peptidomimetics As Aminopeptidase N/CD13 Inhibitors

Xun Li,Junli Wang,Lei Zhang,Wenfang Xu

DOI: https://doi.org/10.1002/ardp.201100109

2011-01-01

Archiv der Pharmazie

Abstract:The synthesis of a series of novel N-alpha-galloylated isoglutamic acid gamma-amide peptidomimetics is described. Their enzymatic inhibition against aminopeptidase N (APN/CD13) and matrix metalloproteinase-2 (MMP-2) was tested. The preliminary activity assay revealed that most of the compounds displayed selective inhibition against APN as compared with MMP-2, with IC(50) values in a micromolar range. Within this series, compound 4 (IC(50) = 10.2 +/- 0.9 mu M) demonstrated comparable APN inhibition as compared with the positive control bestatin (IC(50) = 13.1 +/- 0.7 mu M), which might be a promising lead for further molecular optimizations.
Synthesis of 1,3,4-Thiadiazole Derivatives As Aminopeptidase N Inhibitors

Shao-Hua Li,Gang Li,Hui-Ming Huang,Fang Xiong,Xi Mai,Bin-Hai Kuang,Cheng-Mei Liu,Guo-Gang Tu

DOI: https://doi.org/10.1691/ph.2009.8630

2009-01-01

Abstract:Aminopeptidase N (APN) is a zinc-dependent ectopeptidase which plays an important role in the invasion of metastatic tumors. In this study, we report the synthesis and in vitro enzyme inhibition assay of 1,3,4-thiadiazole scaffold compounds. These new compounds have potent inhibitory activities toward APN with IC50 values in the micromolar range.
Novel Potent 2,5-Pyrrolidinedione Peptidomimetics As Aminopeptidase N Inhibitors. Design, Synthesis and Activity Evaluation

Qianbin Li,Hao Fang,Xuejian Wang,Gaoyun Hu,Qiang Wang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmcl.2011.12.048

IF: 2.94

2012-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A series of novel aminopeptidase N inhibitors with 2,5-pyrrolidinedione scaffold were chemically synthesized. Their preliminary biological activities in enzyme kinetics and cell assay in vitro and anti-metastasis profile in vivo were also evaluated. The results indicated that all the compounds displayed potent inhibitory activity against aminopeptidase N. Compound 8f inhibited aminopeptidase N activity with IC(50) value of 1.0μM and displayed better activity profile in vivo than that of bestatin.
Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

Jiankang Zhang,Jiayi Cao,Lei Xu,Yubo Zhou,Tao Liu,Jia Li,Yongzhou Hu

DOI: https://doi.org/10.1016/j.bmc.2014.04.011

IF: 3.461

2014-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel di‐ and tripeptidyl epoxyketone derivatives composed of β‐amino acids were designed, synthesized and evaluated for their proteasome inhibitory activities and anti‐proliferation activities against two multiple myeloma cell lines RPMI 8226 and NCI‐H929 and normal cells (peripheral blood mononucleated cells). Among these tested compounds, tripeptidyl analogues showed much more potent activities than dipeptides, and four tripeptidyl compounds exhibited proteasome inhibitory activities with IC50 values ranging from 0.97 ± 0.05 to 1.85 ± 0.11 μm. In addition, all the four compounds showed anti‐proliferation activities with IC50 values at low micromolar levels against two multiple myeloma cell lines and weak activities against normal cells. Furthermore, Western blot analysis was performed to verify the proteasome inhibition induced by compounds 21d and 21e. All the experimental results validated that the β‐amino acid building block has the potential for the development of proteasome inhibitors.
Sulfonyl Phosphonic 1,4-Dithia-7-azaspiro[4,4]nonane Derivatives As Matrix Metalloproteinase Inhibitors: Synthesis, a Docking Study, and Biological Evaluation.

Hao Zhang,Xuan Li,Xuejian Wang,Wenfang Xu,Jian Zhang

DOI: https://doi.org/10.5582/ddt.2017.01016

2017-01-01

Drug Discoveries & Therapeutics

Abstract:A series of novel sulfonyl phosphonic 1,4-dithia-7-azaspiro[4,4]nonane derivatives were designed, synthesized, and assayed for their activity against matrix metalloproteinase-2 (MMP-2). Results indicated that all of the compounds exhibited moderate inhibitory activity against MMP-2 compared to LY52 (the control) (IC50 = 0.95 ± 0.09 µM). Several selected compounds were also examined for their antiproliferative activity against SKOV3, HL60, and A549 cells. Notably, all of the tested compounds had slightly lower antiproliferative activity against SKOV3 cells than that of LY52. Compound 6d displayed the greatest inhibitory activity in an enzymatic assay and a cell-based assay, which means that this compound is a good candidate for further development of phosphonate-based MMP inhibitors.
Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.

Qiang Wang,Maoying Chen,Huawei Zhu,Jie Zhang,Hao Fang,Binghe Wang,Wenfang Xu

DOI: https://doi.org/10.1016/j.bmc.2008.04.012

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel L-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N(APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC50 = 13.2 mu M) similar with APN inhibitor Bestatin (IC50 = 15.5 mu M), and could be used as lead compound in the future. (C) 2008 Elsevier Ltd. All rights reserved.

Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Novel 3-Galloylamido-n′-substituted-2,6-piperidinedione-n-acetamide Peptidomimetics As Metalloproteinase Inhibitors

Design, Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Aminopeptidase N/CD13 Inhibitors.

[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].

Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.

Novel Aminopeptidase N Inhibitors Derived from Antineoplaston AS2–5 (part I)

The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

Synthesis and Biological Evaluation of Novel Benzofuroxan-Based Pyrrolidine Hydroxamates As Matrix Metalloproteinase Inhibitors with Nitric Oxide Releasing Activity.

Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).

Synthesis of New Sulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.

Design, Synthesis and Preliminary Activity Evaluation of Novel Peptidomimetics As Aminopeptidase N/CD13 Inhibitors

Synthesis of 1,3,4-Thiadiazole Derivatives As Aminopeptidase N Inhibitors

Novel Potent 2,5-Pyrrolidinedione Peptidomimetics As Aminopeptidase N Inhibitors. Design, Synthesis and Activity Evaluation

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

Sulfonyl Phosphonic 1,4-Dithia-7-azaspiro[4,4]nonane Derivatives As Matrix Metalloproteinase Inhibitors: Synthesis, a Docking Study, and Biological Evaluation.

Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.